Sera Q3 10-Q: $42K Revenue, $72.8M Cash, $25.6M Nine-Month Net Loss
SERA sits 29% above its 52-week low of $1.56 on elevated volume (4.1× avg).
Summary
Sera's Q3 10-Q shows $42,000 of quarterly revenue against an $8.1 million net loss, with $72.8 million in cash and investments and an unused $40.0 million ATM facility.
Key Events · Earnings and Guidance · SERA
-
Q3 Revenue $42K, Net Loss $8.1M
Revenue was $42,000 versus $16,000 a year earlier; net loss was $8.053 million for the quarter and $25.591 million for the nine months, against $7.814 million and $24.047 million in 2025.
-
Cash $72.8M After $22.4M Burn
Cash, cash equivalents and marketable securities totaled $72.8 million at September 30, 2026, after $22.383 million of net cash used in operating activities over nine months; management says this funds operations into 2029.
-
Unused $40M ATM Overhang
The March 18, 2026 at-the-market agreement with William Blair permits sales of up to $40.0 million of Class A stock; no shares were sold under it during the nine months ended September 30, 2026.
-
Restructuring Costs $1.3M Recognized
A May 6, 2026 workforce reduction of 14 full-time employees, about 18% of staff, carried $1.287 million of severance and termination costs, all recognized in the second quarter of 2026.
Analysis · SERA · Industrial Applications And Services
The 10-Q puts hard numbers behind the earnings release furnished the same morning: revenue of $42,000 for the quarter (up from $16,000), a net loss of $8.1 million, and $72.8 million of cash and investments after $22.4 million of nine-month operating burn. For a pre-profit diagnostics company, that cash balance is the whole story — it funds operations into 2029 per management, so there is no near-term financing emergency. The $40.0 million ATM with William Blair remains unused, which means dilution risk is an overhang rather than a realized event. The offsetting negative is that revenue is still immaterial against a $28.3 million nine-month operating expense base, so the path to profitability depends entirely on payer coverage converting into paid test volume.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SERA was trading at $2.02 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $79.5M. The 52-week trading range was $1.56 to $3.85. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.